Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019041127) USE OF CBX4 AS ACTIVATION TARGET FOR HIV-1 LATENT INFECTION
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2019/041127 International Application No.: PCT/CN2017/099466
Publication Date: 07.03.2019 International Filing Date: 29.08.2017
IPC:
A61K 45/00 (2006.01) ,A61P 31/18 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45
Medicinal preparations containing active ingredients not provided for in groups A61K31/-A61K41/132
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12
Antivirals
14
for RNA viruses
18
for HIV
Applicants:
中山大学 SUN YAT-SEN UNIVERSITY [CN/CN]; 中国广东省广州市 海珠区新港西路135号 NO. 135. Xingangxi Road, Haizhu District Guangzhou, Guangdong 510275, CN
Inventors:
张辉 ZHANG, Hui; CN
陈灿灿 CHEN, Cancan; CN
Agent:
广州粤高专利商标代理有限公司 YOGO PATENT AND TRADEMARK AGENCY LIMITED COMPANY; 中国广东省广州市 天河区体育西路191号中石化大厦B塔4416室 Room 4416, Block B, Sinopec Tower No.191, Tiyuxi Road, Tian he District Guangzhou, Guangdong 510620, CN
Priority Data:
Title (EN) USE OF CBX4 AS ACTIVATION TARGET FOR HIV-1 LATENT INFECTION
(FR) UTILISATION DE CBX4 EN TANT QUE CIBLE D'ACTIVATION POUR UNE INFECTION LATENTE PAR LE VIH-1
(ZH) CBX4作为HIV-1潜伏感染激活靶点的应用
Abstract:
(EN) Disclosed is the use of CBX4 as an activation target for HIV-1 latent infection.
(FR) L'utilisation de CBX4 en tant que cible d'activation pour une infection latente du VIH-1 est divulguée.
(ZH) 本发明公开了CBX4作为HIV-1潜伏感染激活靶点的应用。
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)